The Effects of Interferon and Double-stranded RNA upon the Virus–Host Interaction: Studies with Togavirus Strains in Mice

References

1. Anon . 1977; Interferon Options. British Medical Journal 1:64–65
   [Google Scholar]
2. Baron S. 1973; The defensive and biological roles of the interferon system. In Interferon and Interferon Inducers pp 267–293 Edited by Finter N. Amsterdam: North-Holland;
   [Google Scholar]
3. Baron S., Dubuy H., Buckler C. E., Johnson M., Uhlendorf C. 1970; Factors influencing the interferon response by cells to RNA inducers of interferon. In Symposia Series in Immunobiological Standardization: Interferon and Interferon Inducers vol 14: pp 179–184 Basel: S. Karger;
   [Google Scholar]
4. Bowen E., Baskerville A., Cantell K., Mann G., Simpson D., Zuckermann A. 1978; The effect of interferon on experimental Ebola virus infection in rhesus monkeys. In Ebola Virus Haemorrhagic Fever pp 245–252 Edited by Pattyn S. R. Amsterdam: Elsevier/North-Holland Biomedical Press;
   [Google Scholar]
5. Bradish C., Allner K. 1970; The production of mouse interferon in rolling monolayers of L-cells. In Symposia Series in Immunobiological Standardization: Interferon and Interferon Inducers vol 14: pp 35–36 Basel: S. Karger;
   [Google Scholar]
6. Bradish C., Allner K. 1972; The early responses of mice to respiratory and intraperitoneal infection by defined virulent and avirulent strains of Semliki Forest virus. Journal of General Virology 15:205–218
   [Google Scholar]
7. Bradish C., Allner K., Maber H. 1971; The virulence of original and derived strains of Semliki Forest virus for mice, guinea-pigs and rabbits. Journal of General Virology 12:141–160
   [Google Scholar]
8. Bradish C., Allner K., Maber H. 1972; Infection, interaction and the expression of virulence by defined strains of Semliki Forest virus. Journal of General Virology 16:359–372
   [Google Scholar]
9. Bradish C., Allner K., Fitzgeorge R. 1975a; Immunomodification and the expression of virulence in mice by defined strains of Semliki Forest virus: the effects of cyclophosphamide. Journal of General Virology 28:225–237
   [Google Scholar]
10. Bradish C., Allner K., Fitzgeorge R. 1975b; Immunomodification and the expression of virulence in mice by defined strains of Semliki Forest virus: the effects of Myocrisin and 1-asparaginase. Journal of General Virology 28:239–250
    [Google Scholar]
11. Buck K. W., Chain E. B., Himmelweit F. 1971; Comparison of interferon induction in mice by purified Penicillium chrysogenum virus and derived double-stranded RNA. Journal of General Virology 12:131–139
    [Google Scholar]
12. Dunnick J. K., Galasso G. J. 1979; Clinical trials with exogenous interferon: summary of a meeting. Journal of Infectious Diseases 139:109–123
    [Google Scholar]
13. Finter N. 1973 Interferon and Interferon Inducers Amsterdam: North-Holland;
    [Google Scholar]
14. Fitzgeorge R., Bradish C. 1973; Immunospecific isolation of antibodies by dissociation from virus or particulate antigen adsorbed on charcoal. Immunochemistry 10:21–29
    [Google Scholar]
15. Fitzgeorge R., Bradish C. 1980; The in vivo differentiation of strains of yellow fever virus in mice. Journal of General Virology 46:1–13
    [Google Scholar]
16. Friedman R. H. 1977; Antiviral activity of interferons. Bacteriological Reviews 41:543–567
    [Google Scholar]
17. Gifford G., Toy S. 1970; Assay of interferon: general comments. In Symposia Series in Immunobiological Standardization: Interferon and Interferon Inducers vol 14: pp 80–90 Basel: S. Karger;
    [Google Scholar]
18. Gresser I. 1977; On the varied biological effects of interferon. Cellular Immunology 34:406–415
    [Google Scholar]
19. Harrington D. G., Hilmas D. E., Elwell M. R., Whitmire R. E., Stephen E. L. 1977; Intranasal infection on monkeys with Japanese encephalitis virus: clinical response and treatment with a nuclease-resistant derivative of poly(I)-poly(C). American Journal of Tropical Medicine and Hygiene 26(6):1191–1198
    [Google Scholar]
20. Hilleman M. R. 1970; Prospects for the use of double-stranded ribonucleic acid (poly I:C) inducers in man. Journal of Infectious Diseases 121:196–211
    [Google Scholar]
21. Johnson H., Baron S. 1976; Regulatory role of interferons in the immune response. IRCS, Medical Sciences 4:50–52
    [Google Scholar]
22. Radish A., Tansay F., Yu G., Doyle A., Bloom B. 1980; Interferon as a mediator of human lymphocyte suppression. Journal of Experimental Medicine 151:637–650
    [Google Scholar]
23. Levy H. B., London W., Fuccillo D. A., Baron S., Rice J. 1976; Prophylactic control of simian hemorrhagic fever in monkeys by an interferon inducer, polyriboinosinic-polyribocytidylic acid-poly 1-lysine. Journal of Infectious Diseases 133:A256–A259
    [Google Scholar]
24. Merigan T. C., Jordon C. W., Fried R. P. 1975; Clinical utilization of exogenous human interferon. In Perspectives in Virology vol 9: pp 249–268 Edited by Pollard M. New York: Academic Press;
    [Google Scholar]
25. Nathanson N., Cole G. 1971; Immunosuppression: a means to assess the role of the immune response in accute virus infections. Federation Proceedings 30:1822–1841
    [Google Scholar]
26. Perkins F. T., Regamey R. H. (editors) 1970 Symposia series in Immunobiological Standardization: Interferon and Interferon Inducers vol 14: Basel: S. Karger;
    [Google Scholar]
27. Planterose D. N. 1977; Induction of interferons in vivo by ds-RNA’s from natural sources. Texas Reports on Biology and Medicine 35:99–104
    [Google Scholar]
28. Scott G. M., Tyrrell D. A. 1980; Interferon: therapeutic fact or fiction for the 80s. British Medical Journal 280:1558–1563
    [Google Scholar]
29. Sharpe T. J., Birch P. J., Planterose D. N. 1971; Resistance to virus infection during the hyporeactive state of interferon induction. Journal of General Virology 12:331–333
    [Google Scholar]
30. Sonnenfeld G., Mandel A., Merigan T. 1977; The immunosuppressive effect of type II mouse interferon preparations on antibody production. Cellular Immunology 34:193–206
    [Google Scholar]
31. Stephen E. L., Sammons M. L., Pannier W. L., Baron S., Spertzel R. O., Levy H. B. 1977; Effect of a nuclease-resistant derivative of polyriboinosinic-polyribocytidylic acid complex on yellow fever in rhesus monkeys (Macaca mulatto). Journal of Infectious Diseases 136:122–126
    [Google Scholar]
32. Tyrrell D. A. J. 1976 Interferon and Its Clinical Potential London: Heinemann;
    [Google Scholar]
33. Walder R., Bradish C. 1975; Venezuelan equine encephalomyelitis virus: strain differentiation and specification of virulence markers. Journal of General Virology 26:265–275
    [Google Scholar]
34. Walder R., Bradish C. 1979; Multi-factorial specification of virus-host interactions: studies with strains of Venezuelan equine encephalomyelitis virus in mice. Journal of General Virology 44:373–382
    [Google Scholar]
35. World Health Organization 1978; Interferon and other anti-viral agents, with special reference to influenza: a memorandum. Bulletin of the World Health Organization 56(2):229–240
    [Google Scholar]